MarketPulse

pharmaceutical sales

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Yd Bio Limited

YD Bio Posts 17% Revenue Growth to $596.8M, But Swings to Net Loss on Expansion Costs

$YDES reports strong 17% revenue growth to $596.8M in 2025, but net loss of $8.3M as operating expenses surge during business expansion.
YDESYDESWbusiness combinationM&A strategy
BenzingaBenzinga··Vandana Singh

Cardinal Health Beats EPS But Revenue Miss Triggers 8% Stock Plunge

Cardinal Health ($CAH) stock fell 8.23% despite beating EPS estimates, citing revenue miss and stagnant medical products segment despite raised guidance.
CAHstock declinerevenue miss
GlobeNewswire Inc.GlobeNewswire Inc.··Na

United-Guardian Navigates Revenue Decline Amid Cosmetics Headwinds, Pharma Growth

United-Guardian reports 13% sales decline to $10.5M in 2025, hurt by cosmetics weakness and distributor inventory, offset partly by 15% pharmaceutical growth and PBM approvals.
UGChina markettariffs